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The letter of Rapoport [1] demonstrates a 
welcome interest in the problem of the validity of 
ATP-dependent proteolysis in mammalian cells. 
Rapoport suggested that lipoxygenase (LOX) is 
not directly involved in protein degradation of ex- 
ogenously added substrates in reticulocyte ex- 
tracts. This suggestion was based on their 
observations that the LOX inhibitor SHAM does 
not inhibit the degradation of serum albumin [2] 
and that phenylhydrazine-induced reticulocytes are 
qualitatively different from those induced by 
anemia [31. 
We incidentally found that the LOX inhibitor, 
NDGA, also inhibited the newly found protease, 
ingensin [4-10]. It is possible, therefore, that the 
inhibitory effect of SHAM found by Rapoport et 
al. is mediated not by the inhibition of LOX but by 
that of protease itself. Consequently, we consider 
it important to furnish additional evidence that not 
all of the LOX inhibitors also inhibit ATP- 
dependent proteolysis. Secondly, there is no 
evidence that reticulocyte xtracts contain two in- 
dependent proteolytic pathways stimulated by 
ATP, one for endogenous proteins and the other 
for exogenously added proteins. ATP-dependent 
proteolysis can be demonstrated using phenylhy- 
drazine-induced reticulocytes and exogenously 
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added substrates as shown by the authors who first 
discovered ATP-dependent proteolysis [11] and 
the ubiquitin-dependent pathway [12]. Thirdly, 
there is no evidence that almost all of the 
hemoglobin molecules are degraded by an ATP- 
dependent proteolytic system. 
Finally, it is worth emphasizing that the ex- 
periments regarding the purification of protease 
from reticulocyte extracts [13,14] cited by 
Rapoport were conducted in crude extracts and in- 
volved partially purified enzyme. We, therefore, 
regard any data obtained from these experiments 
as less than preliminary. 
ATP-dependent proteolytic activity is generally 
undetectable in crude mammalian cell homoge- 
nates but the workers in the field of protein 
degradation place too much emphasis on the role 
of ATP or ubiquitin as the effectors of protein 
degradation. The questions as to why ATP- 
dependent proteolysis is evident only in reticulo- 
cyte extracts in spite of the undetectable difference 
in the content of ubiquitin and how this system 
works for eliminating so-called 'abnormal pro- 
teins' in the presence of constant levels of the ac- 
tivator, ATP, have not yet been answered. In the 
absence of the purification of these proteolytic en- 
zymes and other components, the conclusion and 
implication seem premature. A more descriptive, 
less speculative work might be of interest to 
workers in the field of protein degradation. We are 
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now trying to purify all of the neutral proteolytic 
enzymes from reticulocyte extracts ([10]; in 
preparation) of which five have been already 
isolated. We hope these studies may ultimately 
clarify the ATP requirement for proteolysis in the 
near future. 
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